Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
Clinical trial NCT06333808 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06333808
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2025-10-27
- Enrollment
- 577
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.